A US Food and Drug Administration panel will discuss the PMA for a system that helps keep donor hearts viable during the transplant process at a 7 October meeting, the agency announced in a Federal Register notice.
The meeting of the Circulatory System Devices Panel, initially scheduled for April, was postponed due to the coronavirus pandemic. It will now be held virtually.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?